Loading
FS
Fibrocell Science, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Maslowski John Michael, was filed 23 Aug 2018.
Fibrocell Science, Inc.: what insiders have been doing
This page follows insider dealings at Fibrocell Science, Inc. as filed with SEC (Form 4). No insider at Fibrocell Science, Inc. has published a filing in the past twelve months. The most recent one dates from 17 December 2019.
Over the whole record (from 2016), the tally stands at 5 purchases and no sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
17
Thresholds
n/a
Buy Volume
€2M
5 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2018FY ended December 2018 · cache
Income statement
Net income-9.2M
Last declaration on 17 December 2019
Declarations17 total
112,617 sharesCommon StockSEC:0001567619-19-023283:6
10,282 sharesCommon StockSEC:0001567619-19-023283:0
291 sharesCommon StockSEC:0001567619-19-023283:2
169,602 sharesCommon StockSEC:0001567619-19-023283:4
80,160 shares@ US$3.004.1% of flowCommon StockSEC:0001567619-19-023283:1
2,453 shares@ US$3.000.1% of flowCommon StockSEC:0001567619-19-023283:3
1,324,328 shares@ US$3.0068.0% of flowCommon StockSEC:0001567619-19-023283:5
539,337 shares@ US$3.0027.7% of flowCommon StockSEC:0001567619-19-023283:7
3,164 shares@ US$3.0061.4% of flowCommon StockSEC:0001628280-19-015076:0
304 shares@ US$3.00100.0% of flowCommon StockSEC:0001628280-19-015079:0
667 shares@ US$3.00100.0% of flowCommon StockSEC:0001628280-19-015083:0
600 shares@ US$3.00100.0% of flowCommon StockSEC:0001628280-19-015073:0
3,000 shares@ US$2.0638.6% of flowCommon StockSEC:0001628280-18-011318:0
Canonical exit: 20 Nov 2018 (T+90)
2,567,121 shares@ US$0.7724.0% of flowCommon StockSEC:0001140361-17-046077:0
Canonical exit: 11 Mar 2018 (T+90)
155,347 shares@ US$0.771.5% of flowCommon StockSEC:0001140361-17-046077:1
Canonical exit: 11 Mar 2018 (T+90)
4,805 shares@ US$0.770.0% of flowCommon StockSEC:0001140361-17-046077:2
Canonical exit: 11 Mar 2018 (T+90)
50,000 shares@ US$0.9217100.0% of flowCommon StockSEC:0000357097-16-000202:0
Canonical exit: 2 Mar 2017 (T+90)
17 of 17 declarations
About Fibrocell Science, Inc.
Fibrocell Science, Inc. is a biopharmaceutical company focused on developing cell therapies to treat skin diseases. The company is listed on NASDAQ under the symbol FCSC.
